Standard
Editorial : safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply. / Dahl, Emilie K.; Abed, Osama K.; Kjeldsen, Jens; Donia, Marco; Svane, Inge M.; Dige, Anders; Agnholt, Jørgen S.; Bjerrum, Jacob T.; Seidelin, Jakob B.
I:
Alimentary Pharmacology and Therapeutics, Bind 57, Nr. 1, 01.2023, s. 152-153.
Publikation: Bidrag til tidsskrift › Leder › Forskning › fagfællebedømt
Harvard
Dahl, EK, Abed, OK, Kjeldsen, J
, Donia, M, Svane, IM, Dige, A, Agnholt, JS
, Bjerrum, JT & Seidelin, JB 2023, '
Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply',
Alimentary Pharmacology and Therapeutics, bind 57, nr. 1, s. 152-153.
https://doi.org/10.1111/apt.17250APA
Dahl, E. K., Abed, O. K., Kjeldsen, J.
, Donia, M., Svane, I. M., Dige, A., Agnholt, J. S.
, Bjerrum, J. T., & Seidelin, J. B. (2023).
Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply.
Alimentary Pharmacology and Therapeutics,
57(1), 152-153.
https://doi.org/10.1111/apt.17250Vancouver
Dahl EK, Abed OK, Kjeldsen J
, Donia M, Svane IM, Dige A o.a.
Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply.
Alimentary Pharmacology and Therapeutics. 2023 jan.;57(1):152-153.
https://doi.org/10.1111/apt.17250Author
Dahl, Emilie K. ; Abed, Osama K. ; Kjeldsen, Jens ; Donia, Marco ; Svane, Inge M. ; Dige, Anders ; Agnholt, Jørgen S. ; Bjerrum, Jacob T. ; Seidelin, Jakob B. / Editorial : safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply. I: Alimentary Pharmacology and Therapeutics. 2023 ; Bind 57, Nr. 1. s. 152-153.
Bibtex
@article{74ca5e96e31746659e15bf2ae4b94a7f,
title = "Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply",
author = "Dahl, {Emilie K.} and Abed, {Osama K.} and Jens Kjeldsen and Marco Donia and Svane, {Inge M.} and Anders Dige and Agnholt, {J{\o}rgen S.} and Bjerrum, {Jacob T.} and Seidelin, {Jakob B.}",
year = "2023",
month = jan,
doi = "10.1111/apt.17250",
language = "English",
volume = "57",
pages = "152--153",
journal = "Alimentary Pharmacology and Therapeutics, Supplement",
issn = "0953-0673",
publisher = "Wiley-Blackwell",
number = "1",
}
RIS
TY - JOUR
T1 - Editorial
T2 - safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply
AU - Dahl, Emilie K.
AU - Abed, Osama K.
AU - Kjeldsen, Jens
AU - Donia, Marco
AU - Svane, Inge M.
AU - Dige, Anders
AU - Agnholt, Jørgen S.
AU - Bjerrum, Jacob T.
AU - Seidelin, Jakob B.
PY - 2023/1
Y1 - 2023/1
U2 - 10.1111/apt.17250
DO - 10.1111/apt.17250
M3 - Editorial
C2 - 36468203
AN - SCOPUS:85143645309
VL - 57
SP - 152
EP - 153
JO - Alimentary Pharmacology and Therapeutics, Supplement
JF - Alimentary Pharmacology and Therapeutics, Supplement
SN - 0953-0673
IS - 1
ER -
